A Latino MSM Focused Pre-Exposure Prophylaxis Uptake Intervention
Evaluating the Feasibility and Acceptability of a Latino MSM Focused PrEP Uptake Intervention
1 other identifier
interventional
105
1 country
1
Brief Summary
The clinical study will evaluate the feasibility and acceptability of a culturally tailored behavioral intervention to improve uptake of pre-exposure prophylaxis for HIV prevention among at-risk Latino men who have sex with men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2022
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedStudy Start
First participant enrolled
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedApril 20, 2026
April 1, 2026
1.9 years
June 9, 2022
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
PrEP initiation
We will assess PrEP uptake using evidence of a prescription for Truvada® or Descovy® (participant shows us their prescription bottle in person or via a text photo).
assessed at 1-month follow-up
PrEP initiation
We will assess PrEP uptake using evidence of a prescription for Truvada® or Descovy® (participant shows us their prescription bottle in person or via a text photo).
assessed at 3-month follow-up
PrEP adherence single measure
We will assess adherence to the PrEP medication using a single-item self-rating adherence measure.
assessed at 1-month follow-up
PrEP adherence single measure
We will assess adherence to the PrEP medication using a single-item self-rating adherence measure.
assessed at 3-month follow-up
PrEP adherence urine sample
We will assess adherence to the PrEP medication by analyzing participants' urine sample to determine the presence of the medication tenofovir, a key medication in the PrEP medication.
assessed at 1-month follow-up
PrEP adherence urine sample
We will assess adherence to the PrEP medication by analyzing participants' urine sample to determine the presence of the medication tenofovir, a key medication in the PrEP medication.
assessed at 3-month follow-up
Secondary Outcomes (2)
Changes in Readiness to Adopt PrEP
assessed at 1-month follow-up
Changes in Readiness to Adopt PrEP
assessed at 3-month follow-up
Study Arms (2)
Latino MSM PrEP intervention
EXPERIMENTALThe Latino MSM PrEP intervention consists of 4 small group sessions with concurrent peer navigation and counseling.
Control condition
ACTIVE COMPARATORThe control condition consists of usual care at the study site (i.e., referrals to PrEP services).
Interventions
Participants will receive an Information, Motivation, and Behavioral skills model PrEP intervention tailored for mixed immigrant status Latino men who have sex with men
Participants will be offered PrEP navigation services as part of usual care at the study site.
Eligibility Criteria
You may qualify if:
- years of age or older
- assigned male at birth
- Identifies as Latino/Hispanic origin
- HIV-negative or HIV status unknown
- Man who has had sex with other men in the past 24 months
- Not currently using PrEP for HIV prevention
You may not qualify if:
- Male under 18 years of age
- Not identifying as being of Latino/Hispanic origin
- Man who has not had sex with other men in the past 24 months
- Identifies as cisgender or transgender Female/woman
- Assigned female at birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bienestar Human Services
Los Angeles, California, 90022, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald A Brooks, PhD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 9, 2022
First Posted
June 28, 2022
Study Start
October 3, 2022
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
April 20, 2026
Record last verified: 2026-04